Your health is important and so is getting answers to the questions you have. We are here to give you the information that will help you make the right decisions for yourself. If you have questions that are not answered on this page or the rest of this site please reach out to us on our Contact Page.
The TULSA Procedure uses the TULSA-PRO® system to transurethrally ablate prostate tissue by combining real-time Magnetic Resonance Imaging (“MRI”) with robotically-driven directional thermal ultrasound to deliver predictable physician-prescribed ablation of whole-gland or partial prostate tissue. For more information on the TULSA Procedure click here.
The TULSA Procedure uses the TULSA-PRO® system to ablate prostate tissue by combining real-time Magnetic Resonance Imaging (“MRI”) with robotically-driven directional thermal ultrasound to deliver predictable physician-prescribed ablation of whole-gland or partial prostate tissue. For more information on the TULSA Procedure click here.
Doctors have been doing the TULSA Procedure once it was approved by the U.S. Food and Drug Administration in 2019.
The PSA test alone is not an indicator that prostate cancer is present. Rather, it is a preliminary test to help your doctor determine whether further testing is required. Click here to learn more about the PSA test and PSA levels.
TULSA Procedure is an outpatient procedure. Following a TULSA Procedure, the patient is usually discharged from the clinic the same day, depending on the doctor’s assessment.
The TULSA Procedure is performed in a single session, and the time of the procedure depends on the treatment plan that’s prescribed by your physician. It is conducted under anesthesia. After the procedure, the patient goes home the same day.
The TULSA-PRO system has been studied in clinical trials. The positive results of the pivotal trial met all of its primary and secondary efficacy and safety endpoints. The clinical trial demonstrated that the TULSA-PRO provides safe and effective prostate tissue ablation, with minimal adverse events, significant prostate volume and PSA reduction, and low rates of residual prostate disease. The favorable safety profile offered by the TULSA-PRO® contrasts with radical prostatectomy and radiation therapy that can leave many men with permanent erectile dysfunction, urinary incontinence and bowel dysfunction. For more information on the success rate, speak to your TULSA Procedure doctor.
If you can’t find what you were looking for, get in touch with us and submit your inquiry:
This website uses cookies to ensure you get the best experience on our website.
